AERI - Aerie Pharmaceuticals, Inc.
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Currency in USD
Valuation measures
| Market cap (intra-day) 5 | 595.21M |
| Enterprise value 3 | 454.21M |
| Trailing P/E | N/A |
| Forward P/E 1 | -10.02 |
| PEG ratio (5-yr expected) 1 | 0.07 |
| Price/sales (ttm) | 8.52 |
| Price/book (mrq) | 3.57 |
| Enterprise value/revenue 3 | 6.50 |
| Enterprise value/EBITDA 6 | -2.68 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.93 |
| 52-week change 3 | -73.14% |
| S&P500 52-week change 3 | -7.45% |
| 52-week high 3 | 46.28 |
| 52-week low 3 | 10.80 |
| 50-day moving average 3 | 15.32 |
| 200-day moving average 3 | 19.74 |
Share statistics
| Avg vol (3-month) 3 | 1M |
| Avg vol (10-day) 3 | 944.78k |
| Shares outstanding 5 | 46.46M |
| Float | 35.96M |
| % held by insiders 1 | 2.08% |
| % held by institutions 1 | 132.40% |
| Shares short (12 Mar 2020) 4 | 11.58M |
| Short ratio (12 Mar 2020) 4 | 9.43 |
| Short % of float (12 Mar 2020) 4 | 29.76% |
| Short % of shares outstanding (12 Mar 2020) 4 | 24.93% |
| Shares short (prior month 13 Feb 2020) 4 | 12.5M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | N/A |
| Trailing annual dividend yield 3 | N/A |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2019 |
| Most-recent quarter (mrq) | 30 Dec 2019 |
Profitability
| Profit margin | -285.57% |
| Operating margin (ttm) | -268.27% |
Management effectiveness
| Return on assets (ttm) | -31.77% |
| Return on equity (ttm) | -101.12% |
Income statement
| Revenue (ttm) | 69.89M |
| Revenue per share (ttm) | 1.54 |
| Quarterly revenue growth (yoy) | 70.60% |
| Gross profit (ttm) | 42.29M |
| EBITDA | -169.38M |
| Net income avi to common (ttm) | -199.58M |
| Diluted EPS (ttm) | -4.39 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 309.19M |
| Total cash per share (mrq) | 6.66 |
| Total debt (mrq) | 206.26M |
| Total debt/equity (mrq) | 123.54 |
| Current ratio (mrq) | 4.50 |
| Book value per share (mrq) | 3.59 |
Cash flow statement
| Operating cash flow (ttm) | -150.43M |
| Levered free cash flow (ttm) | -103.74M |
© 2020 Verizon Media. All rights reserved.